New Key Statistics Module, Z-Score and F-Score
NAS:SYRE Key Ratios
Market Cap $ M | 1,208.74 |
Enterprise Value $ M | 1,013.36 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 142.29 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -72.84 |
Beneish M-Score | -5 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 21.80 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -7.88 |
EV-to-EBITDA | -7.94 |
PEG | -- |
Shares Outstanding M | 36.64 |
Net Margin (%) | -38,238.15 |
Operating Margin % | -14,510.61 |
Pre-tax Margin (%) | -38,241.08 |
Quick Ratio | 10.68 |
Current Ratio | 10.68 |
ROA % (ttm) | -184.88 |
ROE % (ttm) | -- |
ROIC % (ttm) | -269.44 |
Dividend Yield % | -- |
Altman Z-Score | -0.72 |
SYRE Number of Guru Trades
SYRE Volume of Guru Trades
Gurus Latest Trades with NAS:SYRE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SYRE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Spyre Therapeutics Inc Insider Transactions
No Available Data
News about NAS:SYRE
Total 0- 1